Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Raloxifene

Active
SPE2D2-15-R-0002Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract involves the procurement of Raloxifene 60 mg tablets through an unrestricted, fully competitive, firm fixed price arrangement. It is established as a five-year requirements contract, consisting of a one-year base period with four additional one-year option periods. The contract will serve as a national supply source to provide these medications for the Defense Logistics Agency (DLA) and Veterans Affairs (VA) customers via the DLA Medical Prime Vendor Program. Estimated annual usage details will be included in the solicitation's Schedule of Supplies section, and the procurement process follows the Federal Acquisition Regulation (FAR) 12 for commercial items. All sources are eligible to submit proposals, which will be evaluated by the agency. This solicitation is identified under number SPE2D2-15-R-0002, initially posted on March 3, 2015. Documentation and updates related to the solicitation are accessible on the Defense Logistics Agency Bid Board System (DIBBS) website. The primary contact for inquiries is Amanda Houlihan, reachable via email or phone. This contract supports consistent drug supply to meet government healthcare needs across designated customers nationwide.

General Info

Five-year firm fixed price contract for Raloxifene 60 mg tablets, serving DLA and VA nationwide.

Agency

N/A

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhasePresolicitation
Posted

Presolicitation

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A

Full Description

Show more
Raloxifene 60 MG Tablets. Unrestricted Acquisition. Fully competitive, Firm Fixed Price Contract. Five year Requirements Contract with one year base and four 1 year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements Clause), to provide the drugs listed in the schedule for purchase by DLA and VA customers through the DLA Medical Prime Vendor Program. The annual usage for DLA and VA customers served through the Prime Vendor Program will be estimated in the Schedule of Supplies section of the Solicitation. Copy of the Solicitation will be found on the DLA Bid Board System (DIBBS) once it is posted. Website: https://www.dibbs.bsm.dla.mil/RFQ. This is a commercial item and will be solicited using FAR 12. All sources may submit a proposal which shall be considered by the agency.

Similar Contracts

Same NAICS industry code

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS